Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association Between Change in Visual Acuity and Change in Central Subfield Thickness During Treatment of Diabetic Macular Edema in Participants Randomized to Aflibercept, Bevacizumab, or Ranibizumab

Published:2019-09-01 Issue:9 Volume:137 Page:977
ISSN:2168-6165
Container-title:JAMA Ophthalmology
language:en
Short-container-title:JAMA Ophthalmol

Author:

Bressler Neil M.¹²,Odia Isoken³,Maguire Maureen⁴,Glassman Adam R.³,Jampol Lee M.⁵,MacCumber Mathew W.⁶,Shah Chirag⁷,Rosberger Daniel⁸,Sun Jennifer K.⁹¹⁰,

Affiliation:

1. Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland

2. Editor, JAMA Ophthalmology

3. Jaeb Center for Health Research, Tampa, Florida

4. Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania

5. Feinberg School of Medicine, Northwestern University, Chicago, Illinois

6. Rush University Medical Center, Chicago, Illinois

7. Ophthalmic Consultants of Boston, Boston, Massachusetts

8. MaculaCare, New York, New York

9. Joslin Diabetes Center, Beetham Eye Institute, Harvard Department of Ophthalmology Boston, Massachusetts

10. CME Editor, JAMA Cardiology

Publisher

American Medical Association (AMA)

Subject

Ophthalmology

Link

https://jamanetwork.com/journals/jamaophthalmology/articlepdf/2736421/jamaophthalmology_bressler_2019_oi_190039.pdf

Reference18 articles.

1. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.;Elman;Ophthalmology,2010

2. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.;Nguyen;Ophthalmology,2012

3. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.;Wells;N Engl J Med,2015

4. Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies.;Brown;Ophthalmology,2015

5. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema.;Browning;Ophthalmology,2008

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetic retinopathy: New concepts of screening, monitoring, and interventions;Survey of Ophthalmology;2024-11

2. Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available Measures;Ophthalmology Science;2024-09

3. Anti-VEGF therapy for the long-term management of diabetic macular edema: a treat-to-target strategy based on macular morphology;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-07-12

4. Efficacy and Safety of 0.19-mg Fluocinolone Acetonide Implant in Postoperative Cystoid Macular Edema after Pars Plana Vitrectomy;Ophthalmology Retina;2024-07

5. Biosimilar Candidate CT-P42 in Diabetic Macular Edema;Ophthalmology Retina;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3